MXCT
MAXCYTE, INC.
Recent 8-K filings for MXCT
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 20:12 UTC earnings item 2.02item 7.01item 9.01
MaxCyte Q1 revenue $9.7M (-7% YoY); net loss narrows to $4.8M; board authorizes $10M buyback
source · MXCT on sec.gov